Is an aldosterone level of 18 ng/dL acceptable in a patient taking losartan?

Is an Aldosterone Level of 18 ng/dL Acceptable on Losartan?

An aldosterone level of 18 ng/dL while on losartan is elevated and warrants further investigation for primary aldosteronism (PA), as ARBs like losartan artificially raise aldosterone levels and should ideally be withdrawn before definitive screening.

Understanding Losartan's Effect on Aldosterone

Losartan is an angiotensin II receptor blocker (ARB) that directly interferes with aldosterone measurement by blocking the negative feedback loop. When you block angiotensin II receptors:

• Renin increases (loss of negative feedback)
• Aldosterone can paradoxically rise despite the blockade 1
• This creates false-positive screening results for PA

The 2025 Endocrine Society guidelines explicitly state that ARBs should be withdrawn for 2 weeks before accurate aldosterone-renin ratio (ARR) testing if it is safe and feasible 1. Research confirms that losartan significantly lowers baseline aldosterone under controlled conditions (from 1135 to 558 pmol/L, approximately 41 to 20 ng/dL) 2, but this effect varies considerably.

Interpreting Your Result

An aldosterone of 18 ng/dL (approximately 500 pmol/L) while on losartan suggests:

1. This is likely artificially elevated due to the medication
2. The true aldosterone off medication could be lower OR higher - you cannot know without proper testing
3. If renin is suppressed (creating a high ARR), this raises significant concern for PA even on losartan 1

Critical Next Steps:

Check the aldosterone-renin ratio (ARR):

• If ARR >35 (ng/dL per ng/mL/hr) with aldosterone >10 ng/dL, PA screening is positive even on interfering medications 1
• The guidelines note that when aldosterone is 10-15 ng/dL on beta-blockers (which also interfere), PA is still likely if above these thresholds - similar logic applies to ARBs 1

Recommended Action Algorithm

Step 1: Assess Clinical Context

• Check serum potassium - hypokalemia (<3.5 mEq/L) significantly raises PA probability
• Evaluate blood pressure control - resistant hypertension (≥3 drugs including a diuretic) increases pretest probability
• Measure plasma renin alongside aldosterone to calculate ARR

Step 2: Interpret Based on ARR

If ARR >35 with aldosterone >10 ng/dL:

• Proceed to confirmatory testing (saline suppression test or others) 1
• Consider withdrawing losartan for 2 weeks first if blood pressure can be safely controlled with non-interfering agents (calcium channel blockers, alpha-blockers, hydralazine)

If ARR <35 or renin is not suppressed:

• The aldosterone of 18 ng/dL is likely medication-related
• Repeat testing after withdrawing losartan for 2 weeks if feasible 1

If aldosterone 5-10 ng/dL with suppressed renin:

• Repeat on a different day per guidelines 1

Step 3: Medication Adjustment Strategy

Safe to withdraw losartan:

• Switch to non-interfering antihypertensives (verapamil, amlodipine, hydralazine, doxazosin)
• Wait 2 weeks minimum 1
• Recheck aldosterone and renin

Unsafe to withdraw (severe hypertension):

• Proceed directly to confirmatory testing while on losartan
• Accept higher false-positive rate but prioritize patient safety

Important Caveats

Assay Variability

Research shows substantial intra-individual variability in aldosterone measurements (coefficient of variation 22-25%) even off medications 3. A single measurement of 18 ng/dL should not be over-interpreted - at least 2 measurements are recommended before excluding or pursuing PA 3.

Chronic Kidney Disease

If the patient has CKD, both renin and aldosterone can be elevated, leading to increased false-positive screening 1. The FDA label notes losartan is commonly used in renal impairment without dose adjustment 4, but this complicates PA screening.

Age Considerations

Older patients (>50 years) may have different aldosterone dynamics. Research suggests losartan suppression testing may actually be more accurate than captopril testing in this population for confirming PA 5, though this is for confirmatory testing, not screening.

Bottom Line

Do not accept 18 ng/dL as "normal" without checking the ARR and clinical context. If the ARR is elevated with suppressed renin, pursue PA workup regardless of losartan use. If the ARR is normal, the aldosterone level likely reflects medication effect rather than pathology. The safest approach is to withdraw losartan for 2 weeks and remeasure if blood pressure permits, as this eliminates diagnostic uncertainty 1.